RESUMO
Adult NZB mice (greater than 15 wk old) have very few bone marrow cells that can give rise to sIg+ clonable B cells during liquid culture. This deficiency corresponds to extremely low numbers of cells with cytoplasmic but not surface mu chains of IgM and reduced numbers of cells bearing a high molecular weight B-lineage antigen. Depletion of Thy-1-bearing cells and appropriate mixing experiments did not provide evidence either that suppressor cells are responsible for this phenomenon or that accessory cells are defective in NZB mice. Nor did it seem that B cells were being produced in extramedullary sites. B cell precursors were detectable in very young NZB mice, exceeded control values at 4-5 wk of age, and then declined rapidly. In contrast, these persisted for greater than 1 yr in normal BALB/c, DBA/2, and CBA/H mice. It appears possible that intermediate stages in B-lineage differentiation become prematurely exhausted through an accelerated aging process in NZB mice. These chronological changes have implications for understanding the sequence of events that lead to B lymphocyte formation and the processes that normally regulate it.
Assuntos
Envelhecimento , Doenças Autoimunes/imunologia , Linfócitos B/imunologia , Células-Tronco Hematopoéticas/imunologia , Animais , Doenças Autoimunes/genética , Linfócitos B/citologia , Células da Medula Óssea , Adesão Celular , Diferenciação Celular , Feminino , Células-Tronco Hematopoéticas/citologia , Imunidade Celular , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos CBA , Camundongos Endogâmicos DBA , Camundongos Endogâmicos NZB , Receptores de Antígenos de Linfócitos B , Linfócitos T Reguladores/citologia , Linfócitos T Reguladores/imunologiaRESUMO
OBJECTIVE: Neutrophil receptors for the Fc portion of IgG (FcgammaR) trigger immune responses following cross-linking by IgG-coated foreign particles or immune complexes. Membrane-associated CD45, a protein tyrosine phosphatase termed leukocyte common antigen, has been shown to be essential for antigen receptor kinase mediated signaling in lymphocytes, and we hypothesized that CD45 may play a similar role in FcgammaR-mediated signaling and immune function in human neutrophils. METHODS: The experimental approach was that of cell surface molecule ligation via cross-linking with specific antibodies. Antibody dependent cellular cytotoxicity (ADCC) was assessed using a single-cell plaque assay and IL-6 production measured using ELISA. Tyrosine phosphorylation levels were assessed with anti-phospho-tyrosine blots and F-actin polymerization by flow cytometry and confocal microscopy. RESULTS: Neutrophils pretreated with anti-CD45 had a reduced ability to perform ADCC compared to untreated neutrophils. FcgammaRIIa cross-linking resulted in significantly increased concentrations of secreted IL-6 compared to untreated neutrophils, and IL-6 production was further enhanced by cocross-linking CD45 with FcgammaRIIa. Cross-linking CD45 alone also induced IL-6 production. FcgammaRIIa cross-linking resulted in increased protein tyrosine phosphorylation and F-actin polymerization in neutrophils. Cocross-linking CD45 with FcgammaRIIa resulted in abrogation of FcgammaRIIa mediated tyrosine phosphorylation and F-actin polymerization. CONCLUSIONS: These data provide evidence that CD45 can regulate or enhance the stimulation and function of human neutrophils mediated through FcgammaR(s). In addition, CD45 ligation may play an essential role in cytokine induction pathways that lead to inflammatory reactions in vivo.
Assuntos
Antígenos CD/fisiologia , Antígenos Comuns de Leucócito/farmacologia , Ativação de Neutrófilo/efeitos dos fármacos , Receptores de IgG/fisiologia , Actinas/metabolismo , Anticorpos Monoclonais/farmacologia , Citotoxicidade Celular Dependente de Anticorpos/efeitos dos fármacos , Antígenos CD/efeitos dos fármacos , Antígenos CD/metabolismo , Reagentes de Ligações Cruzadas/farmacologia , Fator Estimulador de Colônias de Granulócitos/administração & dosagem , Fator Estimulador de Colônias de Granulócitos/farmacologia , Humanos , Interleucina-6/metabolismo , Antígenos Comuns de Leucócito/imunologia , Antígenos Comuns de Leucócito/fisiologia , Neutrófilos/metabolismo , Neutrófilos/fisiologia , Fosforilação/efeitos dos fármacos , Proteínas Tirosina Fosfatases/farmacologia , Proteínas Tirosina Fosfatases/fisiologia , Receptores de IgG/efeitos dos fármacos , Receptores de IgG/metabolismo , Proteínas Recombinantes/administração & dosagem , Proteínas Recombinantes/farmacologia , Transdução de Sinais/efeitos dos fármacosRESUMO
B lymphocyte production in the bone marrow depends on a cascade of regulatory cells and cytokines unique to the hematopoietic microenvironment. Fibroblastic stromal cells appear to be particularly important in regulating the earliest events in this lineage; however, it is still not clear whether the same or different sets of signals regulate maintenance of cell viability, proliferation, and differentiation of B lineage cells. In this study, we addressed the role of bone marrow stromal cells in survival and expansion of normal murine pro-B cells. Stromal cells were required for long-term proliferation of pro-B cell clone C1.92, and, in the presence of stromal cell line S10, pro-B cells expressed the proto-oncogene bcl-2. Removal of C1.92 cells from Stromal cell-derived signaling in support of pro-B cell viability. Due to its previously described role in regulating cell survival, we investigated whether stromal cells regulate bcl-2 expression in pro-B cells. When removed from stromal cell cultures, pro-B cells rapidly lost bcl-2 mRNA expression coincident with initiation of apoptosis. However, interruption of bcl-2 expression with antisense oligonucleotides in the presence of stroma and interleukin-7 (IL-7) did not result in immediate cell death. Oligonucleotide-treated cells arrested in G(1) phase of the cell cycle 24 hours before the initiation of apoptosis. In contrast, removal of pro-B cells from stromal cell support resulted in rapid increase in BAX expression, correlating directly with initiation of apoptosis. These results suggest that bcl-2 may, in part, regulate cell survival by interrupting the cascade of intracellular events that regulate cell cycle progression in lymphopoietic cells. Initiation of apoptosis in these cells appears to be more closely correlated with intracellular levels of BAX expression.
Assuntos
Linfócitos B/citologia , Células da Medula Óssea , Proteínas Proto-Oncogênicas/metabolismo , Animais , Apoptose , Sequência de Bases , Comunicação Celular , Ciclo Celular , Sobrevivência Celular , Células Cultivadas , Primers do DNA/química , Expressão Gênica , Camundongos , Dados de Sequência Molecular , Proteínas Proto-Oncogênicas c-bcl-2 , RNA Mensageiro/genética , Proteína X Associada a bcl-2RESUMO
This report describes a colony assay system, based on methods used to grow myeloid precursors in semisolid medium, in which B cell progenitors can be grown. The formation of these B cell progenitor colonies is dependent upon soluble mediators from a stromal cell line known to support B lymphopoiesis. In initial experiments a double layer culture system was employed in which target cells in methylcellulose medium were separated from an adherent layer of S17 stromal cells by an agar interface. Target cells were harvested from Dexter type long-term bone marrow cultures at a time after transfer to the lymphoid Whitlock-Witte conditions, when myeloid progenitors were depleted and mature B cells had not yet appeared. On day 15 of culture a colony could be identified that contained several hundred tightly clustered lymphoid cells. There was a linear relationship between the number of cells plated and the number of colonies that developed. Identically appearing colonies were also observed in agar using fresh bone marrow cells as targets with either an underlayer of S17 cells or S17 conditioned medium to potentiate colony growth. Lymphoid colonies derived from fresh bone marrow appeared on days 6 and 14 of growth. A proportion of the cells from the fresh or cultured marrow derived colonies expressed the B220 antigen and cytoplasmic mu heavy chains, but surface IgM was never observed. Cell depletion experiments on antibody coated plates demonstrated the colony forming unit to be B220 antigen positive, surface IgM negative, and replating experiments indicated the colonies were lymphoid restricted in their differentiative potential.
Assuntos
Linfócitos B/fisiologia , Células da Medula Óssea , Ensaio de Unidades Formadoras de Colônias , Animais , Linfócitos B/imunologia , Células Cultivadas , Fatores Estimuladores de Colônias/fisiologia , Feminino , Masculino , Camundongos , Camundongos Endogâmicos BALB C , FenótipoRESUMO
The emergence of putative B lymphocyte lineage cells in embryonic and neonatal tissues of mice was studied using monoclonal antibodies which recognize virtually all B cells, pre-B cells and an additional population of lymphoid cells. An extensive survey of extraembryonic and intraembryonic hemopoietic tissues indicated that cells displaying this marker first appear within liver of 45-50 somite stage embryos. Prior to this developmental stage, none were found in yolk sac or peripheral blood. Although some 14.8 antigen bearing cells were found in suspensions of ectoplacenta, these were small surface IgM+ lymphocytes which were presumably of maternal origin. Culture of embryonic liver fragments which initially contained small numbers of antigen positive cells resulted in their expansion. However, this did not occur when very early liver rudiments containing virtually no lymphoid cells were cultured. These findings document the earliest appearance of cells during ontogeny which may be committed to differentiate into functional B lymphocytes.
Assuntos
Linfócitos B/imunologia , Embrião de Mamíferos/imunologia , Células-Tronco Hematopoéticas/imunologia , Animais , Animais Recém-Nascidos , Anticorpos Monoclonais , Diferenciação Celular , Embrião de Mamíferos/citologia , Fígado/citologia , Fígado/imunologia , Camundongos , Camundongos Endogâmicos CBA , Técnicas de Cultura de ÓrgãosRESUMO
STUDY OBJECTIVE: To evaluate specific biological markers to improve understanding and use of granulocyte colony-stimulating factor (G-CSF) in patients receiving chemotherapy DESIGN: Prospective, randomized study. SETTING: University-affiliated hospital and cancer center. PATIENTS: Twenty-five patients randomized to begin G-CSF either 24 hours after chemotherapy (standard arm), or on the day the absolute neutrophil count (ANC) was below 1000/mm3 after chemotherapy (delayed arm). INTERVENTIONS: To determine the effect of G-CSF on granulopoiesis, peripheral blood mononuclear cells were assayed by semisolid culture medium and flow cytometry for granulocyte progenitors and clonogenic CD34 antigen-positive cells. These biological markers were correlated with G-CSF administration schedules and the ANC. MEASUREMENTS AND MAIN RESULTS: The effect of timing of G-CSF administration on rate of neutrophil recovery, duration of neutropenia, length of G-CSF therapy, delays of chemotherapy cycles, and neutropenic fever events was evaluated. Regardless of G-CSF schedule or chemotherapy regimen, the appearance of mobilized hematopoietic progenitors begins at the neutrophil nadir and parallels granulocyte recovery. Our data also demonstrate that proper timing of G-CSF administration produces similar rates of neutrophil recovery and comparable clinical outcomes. CONCLUSION: Based on the correlation between biological markers and ANC, we propose that the postchemotherapy ANC is a surrogate marker of renewed granulopoietic activity. The relevance of this finding in relationship to the clinical application of G-CSF remains to be further defined.
Assuntos
Antígenos CD34/sangue , Antineoplásicos/efeitos adversos , Fator Estimulador de Colônias de Granulócitos/uso terapêutico , Neoplasias/sangue , Neoplasias/tratamento farmacológico , Neutropenia/tratamento farmacológico , Neutrófilos , Adulto , Idoso , Feminino , Humanos , Contagem de Leucócitos , Masculino , Pessoa de Meia-Idade , Neutropenia/sangue , Neutropenia/induzido quimicamente , Estudos ProspectivosRESUMO
Based upon the above data, it is now possible to formulate a working model that defines the stages of B cell development on which stromal cells and their products act. During the initial stages of this process, pro-B cells which do not express Ig heavy or light chain protein or other non-Ig B lineage associated molecules develop into B220 and c mu expressing pre-B cells in response to a low (< 10 kD) molecular weight stromal cell derived factor. No defined interleukin or colony stimulating factor, including molecules such as KL and IL-7, can replace stromal cell conditioned medium in mediating this developmental step. There appears to be little cell proliferation associated with the differentiation of pro-B cells into pre-B cells. However, our data indicate that as precursors develop into B220 expressing B cell progenitors, they become sensitive to the proliferation stimulating effects of IL-7 and KL. These results are in accord with findings that progenitor cells that have undergone DJH rearrangements are particularly sensitive to KL and IL-7(18,19). The analysis of pre-B cells present in individual lymphoid colonies indicates that once cells have rearranged and expressed their Ig heavy chain genes, they are no longer sensitive to KL and IL-7. These observations are based on the fact that receptors for these cytokines are not expressed in stromal cell dependent pre-B cells and are consistent with kinetic studies showing that the maturation of pre-B cells into surface Ig expressing B lymphocytes is not dependent upon cell proliferation21.(ABSTRACT TRUNCATED AT 250 WORDS)
Assuntos
Subpopulações de Linfócitos B/citologia , Células da Medula Óssea , Fatores de Crescimento de Células Hematopoéticas/fisiologia , Interleucina-7/fisiologia , Diferenciação Celular/efeitos dos fármacos , Divisão Celular , Células Cultivadas , Tecido Conjuntivo/fisiologia , Células do Tecido Conjuntivo , Fibroblastos/fisiologia , Células-Tronco Hematopoéticas/citologia , Células-Tronco Hematopoéticas/efeitos dos fármacos , Modelos Biológicos , Fator de Células-TroncoRESUMO
The immune system of rodents, like that in humans, develops from a population of pluripotential hematopoietic stem cells (HSC) that are generated early in gestation from uncommitted mesenchymal stem cells in the intraembryonic splanchnoplure surrounding the heart. This early population of HSC gives rise to all circulating blood cell lineages, including cells of the innate and acquired immune system. To access the impact of chemical exposure on the developing immune system and establish developmental windows of potential vulnerability to these exposures, it is essential to first consider the anatomical development of hematopoietic and lymphopoietic tissues and the sequence of appearance of cells that give rise to the immune system. This is particularly true in embryonic development because, after they initially appear in intraembryonic mesenchyme early in gestation, HSC migrate through an orderly series of tissues before establishing residence in the bone marrow and thymus. The effect of exposure to chemical insults in utero, then, may differ depending on the specific timing of exposure and anatomical location of hematopoiesis. Mechanisms and consequences of developmental immunotoxicity in experimental animals will need to be considered in that context. This review presents an overview of developmental hematopoiesis and a working hypothesis of critical developmental windows of vulnerability of this developmental system to toxic insult by chemical exposure.
Assuntos
Modelos Animais de Doenças , Sistema Imunitário/embriologia , Sistema Imunitário/crescimento & desenvolvimento , Roedores/imunologia , Toxicologia/métodos , Fatores Etários , Animais , Animais Recém-Nascidos , Medula Óssea/crescimento & desenvolvimento , Hematopoese/efeitos dos fármacos , Hematopoese/imunologia , Células-Tronco Hematopoéticas/efeitos dos fármacos , Células-Tronco Hematopoéticas/imunologia , Sistema Imunitário/efeitos dos fármacos , Fígado/embriologia , Fígado/crescimento & desenvolvimento , Linfopoese/efeitos dos fármacos , Linfopoese/imunologia , Medição de Risco , Baço/embriologia , Baço/crescimento & desenvolvimento , Timo/embriologia , Timo/crescimento & desenvolvimento , Toxicologia/normasRESUMO
Two monoclonal antibodies (MAb) that recognize cell-surface determinants present on bone marrow stromal cells have been generated. The 5B3 antibody recognizes a major histocompatibility class I-like molecule. This antigen is coexpressed on all bone marrow B-lineage cells and myeloid progenitors responsive to recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF). The 9D3 antibody recognizes a protein similar in size to those encoded by the Ly-6 locus. A comparable bone marrow staining pattern and inhibition of 9D3 binding to bone marrow cells by anti-Ly-6C antibodies strongly suggests that the 9D3 antigen is Ly-6C. These data provide a further phenotypic characterization of bone marrow stroma and indicate that these cells express cell-surface determinants also present on myeloid and lymphoid cells.
Assuntos
Antígenos de Superfície/biossíntese , Células da Medula Óssea , Células-Tronco Hematopoéticas/imunologia , Linfócitos/imunologia , Células Estromais/imunologia , Animais , Anticorpos Monoclonais/imunologia , Antígenos de Superfície/imunologia , Medula Óssea/imunologia , Imunofluorescência , Hibridomas/imunologia , Camundongos , Camundongos Endogâmicos BALB C , Ensaio de Radioimunoprecipitação , Baço/citologiaAssuntos
Linfócitos B/citologia , Animais , Células Apresentadoras de Antígenos/fisiologia , Antígenos de Superfície/análise , Linfócitos B/imunologia , Produtos Biológicos/fisiologia , Diferenciação Celular , Células Cultivadas , Citocinas , Hematopoese , Células-Tronco Hematopoéticas/citologia , Humanos , Camundongos , Receptores de Antígenos de Linfócitos B/análise , Fatores de TempoAssuntos
Linfócitos B/citologia , Células da Medula Óssea , Animais , Linfócitos B/efeitos dos fármacos , Medula Óssea/efeitos dos fármacos , Diferenciação Celular/efeitos dos fármacos , Divisão Celular/efeitos dos fármacos , Linhagem Celular , Hematopoese , Fator de Crescimento Insulin-Like I/farmacologia , Interleucina-7/farmacologia , Camundongos , Modelos BiológicosAssuntos
Linfócitos B/citologia , Leucemia Experimental/patologia , Leucemia/patologia , Animais , Linfócitos B/imunologia , Ciclo Celular , Transformação Celular Neoplásica , Células Cultivadas , Humanos , Leucemia/imunologia , Camundongos , Camundongos Endogâmicos NZB , Lesões Pré-Cancerosas/patologiaAssuntos
Linfócitos B/imunologia , Células-Tronco Hematopoéticas/imunologia , Animais , Antígenos de Superfície , Linfócitos B/citologia , Diferenciação Celular , Divisão Celular , Membrana Celular/imunologia , Células-Tronco Hematopoéticas/citologia , Humanos , Cinética , Camundongos , Receptores de Antígenos de Linfócitos BAssuntos
Linfócitos B/citologia , Medula Óssea/fisiologia , Fatores Estimuladores de Colônias/fisiologia , Animais , Linfócitos B/efeitos dos fármacos , Células da Medula Óssea , Diferenciação Celular , Células Cultivadas , Células Clonais , Fatores Estimuladores de Colônias/farmacologia , Modelos BiológicosRESUMO
The development of the B cell immune repertoire was studied using an in vitro fetal organ culture system. In order to analyze the mechanism by which B cell precursors clonally expand and diversify, fetal lymphoid tissues were incubated in the presence of several factors known to influence B cell differentiation: IL-1, IL-2, WEHI-3 culture supernatant containing IL-3, and a factor from a cyclic neutropenia patient (CNF). By analyzing the effect of exogenous factors on the frequency of antigen-responsive B cells, the ability of the factor to either inhibit or enhance clonal expansion was determined. It was found that the addition of IL-1, WEHI-3 supernatant, or CNF increased the frequency of DNP-responsive B cells suggesting an enhancement of clonal expansion. IL-2, on the other hand, did not alter the frequency of antigen-responsive B cells. The effect of added factors on the kinetics of appearance of phosphorylcholine (PC)-responsive B cells, which are known to be acquired in ontogeny about 2 weeks later than DNP-responsive B cells, was also analyzed. The data indicate that CNF, unlike IL-1, IL-2, and WEHI-3 culture supernatant, results in an earlier appearance of PC-responsive B cells. These results suggest that soluble factors may play a role in the generation of the B cell repertoire.
Assuntos
Linfócitos B/citologia , Substâncias de Crescimento/farmacologia , Fígado/imunologia , Animais , Linfócitos B/efeitos dos fármacos , Linfócitos B/transplante , Diferenciação Celular/efeitos dos fármacos , Ensaio de Imunoadsorção Enzimática , Feminino , Feto/imunologia , Haptenos/imunologia , Idiótipos de Imunoglobulinas/análise , Imuno-Histoquímica , Fígado/embriologia , Camundongos , Camundongos Endogâmicos BALB C , Técnicas de Cultura de Órgãos , Células-Tronco/efeitos dos fármacosRESUMO
Two bone marrow stromal cell lines isolated from the adherent layer of a Dexter-type long term bone marrow culture differ markedly in their hemopoietic support capacity. S17 supports myelopoiesis and the differentiation of early B cell precursors into B lymphocytes while S10 supports myeloid cell differentiation and not B lymphopoiesis. The identification of a stromal cell line with B cell support capacity prompted an investigation of whether the effects of S17 were mediated via soluble factors. Results presented herein indicate that medium conditioned by S17 but not S10 contains an activity that can induce the expression of the 220,000 m.w. 14.8 antigen and cytoplasmic mu H chain of Ig in B lymphocyte progenitors that have not yet expressed these markers. Bone marrow cells were depleted of 14.8+, cytoplasmic mu+ pre-B cells on antibody-coated petri dishes. After 24-h liquid culture newly generated pre-B cells were enumerated as cells that expressed cytoplasmic mu H chain of Ig but not Ig L chains by immunofluorescence. Expression of Ly5(220) was monitored by 14.8 antibody binding. This pre-B cell differentiation activity was abrogated by digestion with pronase, aminopeptidase, or carboxypeptidase. Isoelectric focusing data revealed the activity to have isoelectric point of 5.9 to 6.2. S17-conditioned medium was fractionated using HPLC and each fraction tested for pre-B cell-generating activity. Fractions collected from a Superose 12 gel filtration column were found to have two peaks of activity associated with molecules of apparent m.w. of approximately 60,000 and 10,000. Virtually identical peaks of activity were observed when medium conditioned by heterogeneous stromal cell cultures was fractionated. Separation of S10-conditioned medium revealed no cryptic activity. S17-conditioned medium was further characterized by anion exchange chromatography and the majority of the pre-B cell generating activity shown to be associated with the void volume that eluted from a MonoQ column. These fractions were rechromatographed on Superose and the activity again found to be associated with two fractions corresponding to apparent m.w. of 60,000 and 10,000. The S17 pre-B cell differentiation activity appears to result from the presence of a novel molecule because other well characterized mediators had no activity in this short-term liquid culture system. No pre-B cell-generating activity was observed when IL-1 or conditioned medium containing IL-2, IL-3, or IL-4 (B cell stimulatory factor 1) were added to cultures.(ABSTRACT TRUNCATED AT 400 WORDS)
Assuntos
Linfócitos B/imunologia , Células da Medula Óssea , Células-Tronco Hematopoéticas/imunologia , Interleucinas/fisiologia , Ativação Linfocitária , Animais , Linfócitos B/citologia , Medula Óssea/metabolismo , Medula Óssea/fisiologia , Linhagem Celular , Cromatografia em Gel , Cromatografia Líquida de Alta Pressão , Meios de Cultura/farmacologia , Feminino , Células-Tronco Hematopoéticas/citologia , Interleucina-4 , Interleucinas/isolamento & purificação , Interleucinas/metabolismo , Focalização Isoelétrica , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Peptídeo Hidrolases/farmacologiaRESUMO
B lymphocyte development occurs in the intersinusoidal spaces of bone marrow in association with a sessile population of stromal cells. Development of long-term bone marrow culture systems that support B lymphopoiesis has allowed the isolation of stromal cells that support that process and permitted analysis of their role in controlling the growth and differentiation of B lineage cells in culture. In addition to direct interactions with developing lymphocytes, stromal cells secrete a variety of cytokines that affect lymphocyte growth and differentiation, and many of these molecules have been expressed in recombinant form. These relatively recent advances have made it possible to formulate a working model of the cells and molecules involved in regulating primary B cell production.
Assuntos
Linfócitos B/citologia , Células da Medula Óssea , Animais , Diferenciação CelularRESUMO
Our experiments have addressed regulation of B lymphocyte formation by bone marrow stromal cells. Stromal cells appear to produce a regulatory factor that acts at the pre-B cell stage to induce the expression of Ig L chains and surface Ig. Bone marrow stromal cell conditioned medium was found to contain this factor and the active component was partially purified by HPLC. This stromal cell-derived factor had a m.w. between 16,000 and 20,000, was specifically neutralized by anti-IL-4 mAb, 11B11, and enhanced the proliferation of anti-mu-stimulated B cells. We also found that rIL-4 induced B cell formation in culture. In our studies, IL-1 had no direct effect on pre-B cell maturation, however, IL-1 was found to stimulate the production of IL-4 by both heterogeneous bone marrow stromal cells and a cloned stromal cell line, SCL-160. These effects of IL-1 on factor production by stromal cells were duplicated by the addition of bone marrow-derived macrophages to SCL-160 cells. We conclude that stromal cell-derived IL-4 is a physiologic stimulator for B cell generation. In addition, macrophages appear to play a role in B cell formation by regulating the production of IL-4 by stromal cells via the secretion of IL-1.
Assuntos
Linfócitos B/fisiologia , Células da Medula Óssea , Matriz Extracelular/fisiologia , Hematopoese , Interleucina-1/fisiologia , Interleucinas/fisiologia , Macrófagos/fisiologia , Animais , Anticorpos Monoclonais/fisiologia , Diferenciação Celular/efeitos dos fármacos , Células Cultivadas , Cromatografia Líquida de Alta Pressão , Meios de Cultura/análise , Hematopoese/efeitos dos fármacos , Células-Tronco Hematopoéticas/fisiologia , Interleucina-1/análise , Interleucina-1/imunologia , Interleucina-4 , Interleucinas/análise , Interleucinas/imunologia , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Proteínas Recombinantes/farmacologia , Baço/citologiaRESUMO
Bone marrow stromal cells appear to be key regulatory elements in hematopoiesis and lymphopoiesis. These stromal cells respond to cytokine exposure and alter their pattern of hematopoietic growth factor production, suggesting a degree of functional plasticity. We examined the effect of two cytokines, interleukin-1 (IL-1) and IL-4, on stromal cell regulation of pre-B cell generation using the bone marrow stromal cell line, S17. Neither lymphokine potentiated pre-B cell generation in the absence of stromal cells. However, addition of either 10 U/mL rIL-1 alpha or 50 U/mL rIL-4 to cultures of bone marrow cells containing S17 cells dramatically suppressed subsequent pre-B cell formation. Preculture of S17 stromal cells with either rIL-1 or rIL-4 completely abrogated their ability to support pre-B cell generation in subsequent coculture with freshly explanted bone marrow cells. Conditioned medium from IL-1- or IL-4-treated S17 cells also suppressed pre-B-cell generation in culture. Although it is not yet known which induced stromal cell factors are responsible for failure of pre-B-cell generation in treated cultures, these data do clearly demonstrate that local levels of IL-1 and IL-4 in the hematopoietic microenvironment may play a significant role in regulation of bone marrow stromal cell function. These data also demonstrate that fibroblastic stromal cells are primary target cells that respond to cytokine concentration and affect lymphopoietic cell development.